Unstable Angina Treatment Guidelines
For adults presenting with unstable angina, immediately initiate aspirin (75-325 mg), add a P2Y12 inhibitor (ticagrelor 180 mg loading dose preferred, or clopidogrel 300-600 mg if ticagrelor unavailable), start anticoagulation with unfractionated heparin or enoxaparin, and administer beta-blockers and nitrates for symptom control, followed by urgent risk stratification to determine need for early invasive coronary angiography within 12-24 hours for high-risk patients. 1, 2
Initial Medical Management (First 24 Hours)
Antiplatelet Therapy - Cornerstone of Treatment
Aspirin:
- Administer 75-325 mg immediately upon presentation 3, 1
- Continue indefinitely at 81 mg daily maintenance dose when combined with ticagrelor 4, 2
P2Y12 Inhibitor (Dual Antiplatelet Therapy):
- Ticagrelor is preferred: 180 mg loading dose, then 90 mg twice daily 1, 2
- Clopidogrel alternative: 300-600 mg loading dose, then 75 mg daily 1, 5
- Prasugrel: Only after coronary anatomy is defined at catheterization (60 mg loading, then 10 mg daily), contraindicated if prior stroke/TIA 4, 1
- Initiate P2Y12 inhibitor as soon as possible upon presentation, before angiography 1, 2
Anticoagulation
Select one of the following 3, 1:
- Unfractionated heparin (UFH): Continue for at least 48 hours 3
- Enoxaparin (LMWH): Continue for duration of hospitalization, up to 8 days 3
- Fondaparinux: 24-hour dosing, continue for hospitalization duration 3
- Bivalirudin: May continue up to 72 hours at physician discretion 3
Anti-Ischemic Therapy
Beta-blockers:
- Initiate early unless contraindicated 6, 7
- Use calcium channel blockers only if beta-blockers contraindicated or not tolerated 6, 7
Nitrates:
Risk Stratification (Within 6-12 Hours)
High-Risk Features Requiring Early Invasive Strategy 6, 7
Patients with ANY of the following should undergo coronary angiography within 12-24 hours 1, 8:
- Recurrent ischemia (chest pain or dynamic ST-segment changes) 6, 7
- Elevated troponin levels 6, 7
- Hemodynamic instability (hypotension, pulmonary edema) 6, 7
- Major arrhythmias (ventricular tachycardia, ventricular fibrillation) 6, 7
- Early post-infarction unstable angina 6, 7
- ST-segment depression ≥0.5 mm 6, 7
- Diabetes mellitus 7
- GRACE risk score >140 8
GP IIb/IIIa Inhibitors for High-Risk Patients
Before or during PCI in troponin-positive high-risk patients 3:
- Abciximab, eptifibatide, or tirofiban
- Start before angiography and continue 12-24 hours post-PCI 6, 7
- May be omitted if bivalirudin used AND clopidogrel ≥300 mg given ≥6 hours prior 3
Invasive Management Strategy
Coronary Angiography Timing 7, 8
Immediate (<1 hour): Severe ongoing ischemia, hemodynamic instability, major arrhythmias 7
Early (12-24 hours): All other high-risk patients 8
Within 48 hours: Most high-risk patients if stabilized 7
Revascularization Decisions 6, 7
Single-vessel disease: PCI of culprit lesion is first choice 6, 7
Left main or triple-vessel disease: CABG recommended, especially with LV dysfunction 6, 7
Double-vessel disease: Either PCI or CABG appropriate based on anatomy 6, 7
Staged procedures: Consider immediate PCI of culprit lesion with subsequent reassessment for additional lesions 6, 7
Medication Management Around Procedures
Before CABG 3
- Continue aspirin 3
- Discontinue clopidogrel 5-7 days before elective CABG 3, 1
- Discontinue prasugrel 7 days before 4
- Discontinue ticagrelor 5 days before 4
- Discontinue GP IIb/IIIa inhibitors 4 hours before 3
- Continue UFH; discontinue enoxaparin 12-24 hours before; discontinue fondaparinux 24 hours before 3
For PCI Patients 3
- Continue aspirin 3
- Administer P2Y12 inhibitor loading dose if not already given 3
- GP IIb/IIIa inhibitor for troponin-positive patients if not started upstream 3
- Discontinue anticoagulation after uncomplicated PCI 3
Duration of Dual Antiplatelet Therapy
Standard approach: Continue DAPT for at least 12 months post-ACS 4, 1, 2
Alternative bleeding reduction strategy (post-PCI): Aspirin discontinuation with ticagrelor monotherapy after 1-3 months may reduce bleeding while maintaining efficacy 2
High bleeding risk patients: Consider shorter DAPT duration (1-3 months) followed by single antiplatelet therapy 2
Low-Risk Patients (Conservative Strategy)
For patients WITHOUT high-risk features 7:
- Continue aspirin, P2Y12 inhibitor, and anticoagulation
- Perform stress testing if LVEF >0.40 3
- Consider angiography if LVEF ≤0.40 3
- If recurrent symptoms develop, proceed to angiography 1
Critical Pitfalls to Avoid
Do not delay P2Y12 inhibitor: Start immediately upon presentation, not just before PCI 1, 2
Do not withhold clopidogrel due to potential CABG: The mortality benefit outweighs bleeding risk; can discontinue 5-7 days before surgery if needed 1, 5
Do not use prasugrel before knowing coronary anatomy: Risk of bleeding with CABG, and contraindicated with prior stroke 4, 1
Do not continue GP IIb/IIIa inhibitors beyond 12-24 hours post-PCI: Increases bleeding without additional benefit 6, 7
Do not discharge high-risk patients without angiography: Troponin elevation, ST-depression, or recurrent ischemia mandate invasive evaluation 6, 7, 8